RALBP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.7972290322632E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.5508000680079E-10 |
Normal-vs-Stage2 |
1.39359999995481E-06 |
Normal-vs-Stage3 |
6.4601000004938E-07 |
Normal-vs-Stage4 |
1.956380E-04 |
Stage1-vs-Stage2 |
6.979400E-01 |
Stage1-vs-Stage3 |
8.548000E-01 |
Stage1-vs-Stage4 |
6.350400E-01 |
Stage2-vs-Stage3 |
5.660200E-01 |
Stage2-vs-Stage4 |
8.316800E-01 |
Stage3-vs-Stage4 |
5.088000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.34300000512278E-08 |
Normal-vs-AfricanAmerican |
2.218900E-04 |
Normal-vs-Asian |
4.64910000053109E-07 |
Caucasian-vs-AfricanAmerican |
9.216200E-02 |
Caucasian-vs-Asian |
6.090200E-01 |
AfricanAmerican-vs-Asian |
5.283600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62592161956354E-12 |
Normal-vs-Female |
3.47519999999157E-06 |
Male-vs-Female |
8.988400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
4.28299999910564E-08 |
Normal-vs-Extreme_Weight |
3.19600002018916E-09 |
Normal-vs-Obese |
1.1996000004455E-07 |
Normal-vs-Extreme_Obese |
2.213800E-01 |
Normal_Weight-vs-Extreme_Weight |
2.013800E-01 |
Normal_Weight-vs-Obese |
8.028800E-01 |
Normal_Weight-vs-Extreme_Obese |
5.291000E-01 |
Extreme_Weight-vs-Obese |
3.556400E-02 |
Extreme_Weight-vs-Extreme_Obese |
3.660600E-01 |
Obese-vs-Extreme_Obese |
5.611600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.848300E-04 |
Normal-vs-Age(41-60Yrs) |
1.91709981223198E-11 |
Normal-vs-Age(61-80Yrs) |
2.01380023767683E-11 |
Normal-vs-Age(81-100Yrs) |
3.33049999801105E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.377400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.608800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.657900E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.203200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.688400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.175600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.25050000354676E-08 |
Normal-VS-Type2 PRCC |
9.36180000188358E-09 |
Normal-VS-KIRP CIMP |
1.262420E-01 |
Normal-VS-Unclassified PRCC |
2.23100000029675E-07 |
Type1 PRCC-VS-Type2 PRCC |
4.538400E-01 |
Type1 PRCC-VS-KIRP CIMP |
2.302200E-02 |
Type1 PRCC-VS-Unclassified PRCC |
2.845400E-01 |
Type2 PRCC-VS-KIRP CIMP |
2.768400E-02 |
Type2 PRCC-VS-Unclassified PRCC |
8.347000E-01 |
KIRP CIMP-VS-Unclassified PRCC |
1.031600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.23990000489016E-08 |
Normal-vs-N1 |
2.01159999999589E-05 |
Normal-vs-N2 |
4.612000E-02 |
N0-vs-N1 |
2.374200E-02 |
N0-vs-N2 |
6.763000E-01 |
N1-vs-N2 |
8.005800E-01 |
|
|